Comparison of the injection-site experience of semaglutide in a single-dose and a multidose pen-injector

Diabetes Obes Metab. 2022 Aug;24(8):1643-1646. doi: 10.1111/dom.14718. Epub 2022 May 20.
No abstract available

Keywords: clinical trial; excipient; pain; phenol; propylene glycol; subcutaneous injection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Glucagon-Like Peptides* / adverse effects
  • Humans
  • Injections, Subcutaneous

Substances

  • semaglutide
  • Glucagon-Like Peptides

Associated data

  • ClinicalTrials.gov/NCT04007107
  • ClinicalTrials.gov/NCT04143945
  • EudraCT/2019-002284-10
  • EudraCT/2019-003654-83